46. Malignant rheumatoid arthritis Clinical trials / Disease details

Clinical trials : 4,325 /  Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT05003310
(ClinicalTrials.gov)		October 19, 20215/7/2021Splenic Stimulation for RAMultipart Exploratory Study to Evaluate Splenic Nerve Stimulation in Patients With Rheumatoid ArthritisRheumatoid ArthritisDevice: Active Stimulation;Device: Sham Stimulation;Drug: Baricitinib;Drug: Background TreatmentGalvani BioelectronicsNAMSA;Q2 SolutionsRecruiting22 Years75 YearsAll28N/AUnited States
2NCT04539964
(ClinicalTrials.gov)		January 11, 202131/8/2020Vagus Nerve Stimulation for Moderate to Severe Rheumatoid ArthritisVagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA StudyRheumatoid ArthritisProcedure: Implant Procedure;Drug: Conventional Synthetic DMARD;Device: Active stimulation;Device: Non-active stimulationSetPoint Medical CorporationNULLRecruiting22 Years75 YearsAll250Phase 3United States